Abstract. In this paper, the synthesis and characterization of some imidazole-based gold-selenolates are described. This study indicates that the nature of selenolate plays an important role in ligand exchange reactions in gold(I) selenolates. Furthermore, the reactivity of imidazole-based gold(I) selenolates toward nucleophiles such as selenols and phosphines is strikingly different from that of the N,N-dimethylaminobenzylamine-based gold(I) complexes. The presence of Se· · · N non-bonded interactions in N,N-dimethylaminobenzylamine-based gold(I) complexes modulates the reactivity of Au(I) centre towards incoming nucleophiles.
Introduction
Gold(I) complexes such as auranofin (1, AUR), gold thioglucose (2, GTG) and gold thiomalate (3, GTM) (figure 1) have been used as therapeutic drugs for Rheumatoid Arthritis (RA) for a long period of time. 1 The biochemical mechanism for the action of these compounds in RA is complex as these compounds interact with several biomolecules. Owing to the higher affinity of gold(I) towards sulfur and selenium, gold(I) drugs rapidly react with activated cysteine or selenocysteine residues of enzymes to form protein-gold(I)-thiolate or protein-gold(I)-selenolate complexes. 2 It is known that the gold(I) drugs rapidly bind to the most abundant plasma protein serum albumin (Alb-SH) after their administration, which is important for the transport of these drugs. 3 The interaction of AUR with Alb-SH has been studied extensively in recent years and these studies reveal that AUR reacts with the active site cysteine residue (Cys-34) of Alb-SH to produce the corresponding albumin-gold(I)-phosphine (Alb-SAu-PEt 3 ) complex. 3 Similarly, the gold-phosphole complex 4 has been shown to react with the Cys-284 of human glutathione reductase (hGR) to produce a stable protein-gold(I)-phosphole (Cys284-S-Au-phosphole) complex. 4 Interestingly, gold(I) drugs effectively inhibit several seleno- * For correspondence enzymes such as glutathione peroxidase (GPx), 5 thioredoxin reductase (TrxR) 6 and iodothyronine deiodinase (ID-1), 7 by forming gold(I)-selenolate complexes with the selenocysteine (Sec) residues at the active sites. The formation of gold(I)-selenolate complexes in proteins appears to be more facile than the formation of gold(I)-thiolates. For example, the substitution of Sec in ID-1 by a Cys residue significantly reduced the sensitivity of the enzyme toward GTG. 7 Recently, we have shown that trialkyl/aryl gold(I) chlorides (R 3 PAuCl, R = Me, Et or Ph) inhibit the GPx activity of the selenol 5 by forming gold(I)-selenolate complexes (6) (7) (8) . 8 Gimeno and co-workers reported similar gold-selenolates (9-10) bearing the N,N-dimethylbenzylamine moiety (figure 2). 9 It has been reported that the amino group in 5 plays an important role in the GPx activity as the Se· · · N non-covalent interactions in the key catalytic intermediates modulate the catalytic activity. 8, 10 In the natural GPx enzyme, two amino acid residues, glutamine (Gln) and tryptophan (Trp), form a 'catalytic triad' with the Sec residue at the active site. 11 In ID-1 and TrxR, histidine residues (His) have been shown to play crucial roles in the catalysis.
12 However, it is not known whether these proximal amino acid residues modulate the reactivity or stability of the gold-selenolate complexes during inhibition by gold(I) complexes. In this paper, we describe, for the first time, the mode of ligand exchange reactions at Au(I) center in goldselenolates in the presence or absence of any Se· · · N interactions. 
Experimental

General procedure
Trimethylphosphine gold(I) chloride, triethylphosphine gold(I) chloride, triphenylphosphine gold(I) chloride and sodium borohydride were purchased from SigmaAldrich. The experiments were carried out under dry and oxygen-free nitrogen using standard Schlenk techniques for the synthesis. 
General procedure for the reaction of goldselenolates with selenolate and phosphines
The reactions of gold-selenolates 13-15 with selenolate 12 and triphenylphosphine (PPh 3 ) were carried out in NMR tube using MeOH as solvent. To a methanolic solution of complexes 13-15, was added required amount of either selenolate 12 (freshly prepared by the reduction of the corresponding diselenide 11) or PPh 3 .
The resultant solution was mixed thoroughly and then studied by 77 Se, 31 P NMR and ESI-MS techniques to understand the ligand exchange reactions and to analyse the final products.
X-ray crystallography
Single crystal X-ray diffraction data was collected on a Bruker AXS SMART APEX CCD diffractometer at room temperature (291 K). The X-ray generator was operated at 50 KV and 35 mA using Mo-Kα radiation (λ = 0.71073 Å). The data was collected using SMART software package.
14 The data were reduced by SAINTPLUS, 14 an empirical absorption correction was applied using the package SADABS 15 and XPREP 14 was used to determine the space group. The crystal structure was solved by direct methods using SIR92 16 and refined by full-matrix least-squares method using SHELXL97. 17 All non-hydrogen atoms were refined anisotropically and hydrogen atoms were assigned at idealized locations.
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Results and discussion
Synthesis of gold(I)-selenolates
The imidazole-based gold-selenolates 13-15 were synthesized by treating R 3 PAuCl (R = Me, Et or Ph) with the selenolate 12 (scheme 1). The diselenide 11 can be quantitatively reduced to the corresponding selenol 12 by the treatment of NaBH 4 . 13 The selenol produced in this reaction exists predominantly in its zwitterionic form (2B) having a large negative charge on selenium atom as shown in scheme 1. A nucleophilic attack of the selenol 12 at the Au(I) centre of R 3 PAuCl produces the corresponding gold-selenolates 13-15 almost in quantitative yields. All the gold-selenolates were characterized by NMR ( 1 H, 13 C, 31 P and 77 Se) spectroscopic and ESI-MS spectrometric techniques.
Structural features of gold(I)-selenolate 13
To understand the important structural features in the gold-selenolates, complex 13 was studied by single crystal X-ray diffraction. After the synthesis of complex 13 in chloroform, the crude compound was recrystallized from chloroform/methanol (1:1) mixture to afford faint yellowish needle-shaped crystals. As shown in figure 3 , the structure of complex 13 was found to be dimeric with a weak Au· · · Au non-covalent aurophilic interaction (dAu1· · · Au2 = 3.104 Å), which was much shorter than the sum of van der Waals radii of Au atoms (3.40 Å).
As expected, an almost linear arrangement of SeAu-P moieties were observed (θSe1-Au1-P1: 175.9 o and θSe2-Au2-P2: 172.4 o ), which is a characteristic of Au(I) complexes. 4, 9 A small deviation from the linearity is probably due to the presence of Au· · · Au aurophilic interaction. Similar structural features were also observed for complexes 9 and 10 as reported by Gimeno and co-workers. 9 While the Au· · · Au distance of 3.104 Å in complex 13 is comparable to that of 9 (3.091 Å), the distance is found to be slightly longer than that reported for complex 10 (3.024 Å). Although two Cl − counterions were present in the crystal structure of complex 13, both of the Cl − ions were far away from the Au and Se centres. Furthermore, both the Cl − ions were located nearer to one imidazole-goldselenolate unit. For example, the distance of Cl − ions from Au2 and Se2 are found to be much higher than the distance from Au1 and Se1 centres. However, all these distances are much higher than the sum of van der Waals distance of Se/Au and Cl atoms indicating the absence of any non-bonded interactions (table 1).
Ligand exchange reactions in gold(I)-selenolates
It has been shown that ligand exchange reactions play an important role in the inhibition of GPx.
5 For example, GTG undergoes ligand displacement reactions with glutathione (GSH) to produce [Au(SG) 2 ] − complex, which is probably responsible for the inhibition of the enzyme. 5c The synthetic gold-selenolate complexes 6-8 also undergo extensive ligand exchange reactions in the presence of selenol 5 and phosphines. 8 In these reactions, the trialkyl/aryl phosphines were eliminated, which underwent further reactions with oxygen and selenium powder to produce the corresponding phosphine oxides (R 3 P=O) and selenides (R 3 P=Se). 8 In contrast, reactions of the imidazole-based selenol 12 with trialkyl/aryl gold chlorides produced the corresponding gold-selenolates (13-15) and the formation of phosphine oxides or selenides was not observed. These observations indicate that the Se· · · N interactions in complexes 6-8 may activate the S-Au and Au-P bonds toward ligand displacement reactions. When complex 6 was treated with 5, the formation of bis-selenolate-gold complex 16 was observed due to the replacement of the phosphine ligand by the selenol (scheme 2). 8 In contrast, no such reaction was observed when complex 14 was treated with an equimolar amount of compound 12. Although a small amount of triethyl phosphine oxide (Et 3 P=O) was observed in the reaction, the ESI-MS spectrum indicated that the selenolate and phosphine ligands are intact in complex 14 (figures S13 and S14 of Supporting Information). These observations indicate that the notable differences in reactivity of complexes 6-8 and 14 towards corresponding selenols are probably due to the differences in nucleophilicity/basicity of -NMe 2 and Cl − moieties. A striking difference in the reactivity of these two types of gold-selenolates toward selenols prompted us to investigate the phosphine exchange reactions. As Table 1 . Some important bond distances, bond angles and non-bonding distances in the crystal structure of complex 13. shown previously, addition of PPh 3 to the benzylaminebased gold-selenolate complexes 6-7 leads to a rapid elimination of PMe 3 or PEt 3 to produce complex 8.
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In contrast, the imidazole-based gold-selenolates 13-14 do not undergo any phosphine displacement reactions in the presence of PPh 3 . For example, the treatment of 14 with an excess amount (∼5 equiv) of PPh 3 does not produce the phosphine-exchanged product 15. − counterions as shown in scheme 3. As expected, a line broadening in 31 P NMR signal was observed during the course of phosphine exchange reactions. Although there is no direct evidence, the elimination of selenolate in the reaction of 14 with PPh 3 is probably due to the stronger trans effect of the phosphine ligand as compared to the selenolate ligand, which leads to the weakening of the Au-Se bond. Whereas, the Se· · · N interactions in the benzylaminebased gold-selenolates 6-8 may reduce the trans directing effect of phosphine group, leading to the weakening of the Au-P bonds. This may facilitate the phosphine exchange reactions as shown in scheme 3. These observations lead to the assumption that the nonbonded interactions at the selenium centres in goldselenolates may modulate the ligand exchange reactions at the Au(I) centres. 
Possible pathways of different ligand exchange reactions
Coffer et al. have previously shown that the nucleophilic attack of the Cys-34 residue of albumin at the Au(I) centre of AUR leads to the formation of proteingold-phosphine (Alb-S-AuPEt 3 ) complex, indicating that the replacement of thioglucose moiety is more favoured than that of the PEt 3 ligand. 3a However, it is not clear whether the elimination of gold(I)-phosphine moiety from an enzyme active site alters the inhibition property of the gold(I) complexes. The present study indicates that the nature of selenolate can alter the ligand exchange reactions at the gold(I) centre. This study also suggests that the effect of gold(I) drugs on selenoenzymes not only depends on the reactivity of Sec toward these gold(I) complexes, but also the stability of Se-Au bond in the enzyme-bound complex. For example, the presence of a ligand (L) in biological medium may have different effects on the gold(I)-selenocysteine complexes as shown in scheme 4. In the first scenario, the addition of L does not lead to any ligand displacement reactions. In such case, the enzyme activity is expected to be strongly inhibited by the treatment of enzyme with gold(I) complexes such as AUR. In the second pathway, the replacement of phosphine ligand by L may not affect the inhibition as the Sec residue is still bonded to the gold(I) moiety. In contrast, a recovery of enzyme activity is expected when the ligand L attacks at the Au(I) centre to release the catalytically active selenol (scheme 4). Therefore, the ligand exchange reactions at the Au(I) centres in proteingold complexes may or may not affect the inhibition of enzymatic activity depending on the relative strength of protein(Sec)-gold and gold-phosphine bonds. Furthermore, this scheme indicates that, for an effective inhibition of selenoenzymes by gold(I) drugs, the SeAu bond should be more stable than that of the Au-P bonds.
Conclusion
In summary, some imidazole-based gold(I)-selenolates have been synthesized, characterized and studied for their reactivity towards different nucleophiles. This study indicates that the nature of selenolate plays an important role in ligand exchange reactions in gold-selenolates. The reactivity of the imidazolebased gold(I)-selenolates toward selenols and phosphines is significantly different from that of the N,Ndimethylbenzylamine-based gold(I) complexes. The strong trans effect of phosphines probably makes the Au(I)-Se bond relatively weaker, leading to the cleavage of Au(I)-Se bond in gold(I)-selenolates upon the nucleophilic attack of selenols and phosphines. These observations suggest that the effect of gold(I) drugs on selenoenzymes may not only depend on the reactivity of Sec toward these gold(I) complexes, but also on the stability of Se-Au bond in the gold(I)-selenolate complex of the enzyme.
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